EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
37 hedge funds and large institutions have $90.4M invested in Eucrates Biomedical Acquisition Corp. Unit in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
DM
Deerfield Management
New York
|
+$10.7M |
2 |
BlackRock
New York
|
+$9.86M |
3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.17M |
4 |
6CM
683 Capital Management
New York
|
+$6.4M |
5 |
BI
BVF Inc
San Francisco,
California
|
+$5.33M |
Top Sellers
No sellers this quarter